An Herbal Remedy Exhibiting Potent Therapeutic Effects Against Respiratory Infectious Diseases in Humans, Including Covid-19 and Influenza

Authors

  • Jiangnan Feng Tongrun Tang Traditional Chinese Medicine Clinic, Nanchong,China
  • Xianfu Li Zhognde Institute of Psychology, Wuhan, China
  • Xue Feng Tongrun Tang Traditional Chinese Medicine Clinic, Nanchong, China
  • Shuzhen Wang Center for Disease Control and Prevention, Qichun, China
  • Xia Liu Tongrun Tang Traditional Chinese Medicine Clinic, Nanchong, China
  • Minghai Ma Tongrun Tang Traditional Chinese Medicine Clinic, Nanchong, China
  • Dengbin Zhu Tongrun Tang Traditional Chinese Medicine Clinic, Nanchong, China
  • Meiying Gao Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
  • Chengsheng Yi Tongrun Tang Traditional Chinese Medicine Clinic, Nanchong, China
  • Zhenghua Ma Tongrun Tang Traditional Chinese Medicine Clinic, Nanchong, China
  • Yu Yan Tongrun Tang Traditional Chinese Medicine Clinic, Nanchong, China

Abstract

Background: There is no specific evidence-based therapy with proven efficacy for COVID-19. Marecipe AV, an ancient Chinese herbal compound, has been utilized in our clinic for over a decade to treat viral infectious diseases, demonstrating remarkable therapeutic benefits. We hereby present the outcomes of using Marecipe AV herbal therapeutics for the treatment of COVID-19 and influenza at our clinic during the outbreak in China.

Methods: The efficacy of Marecipe AV in treating COVID-19 was assessed through a comparative analysis of the duration of fever, the time to sustained resolution of clinical symptoms, and the incidence of hospitalization due to progression to severe COVID-19 between a treated patient cohort and an untreated control group. The efficacy of Marecipe AV in treating influenza was evaluated by comparing the duration of influenza-associated fever among the treatment group, the preventive treatment group, and the control group.

Results: Data were collected from 524 individuals diagnosed with COVID-19, of whom 159 received Marecipe AV, while 365 did not. All 122 patients treated with Marecipe AV experienced resolution of fever within 24 hours of initiating treatment, with the COVID-19 clinical course concluding within the subsequent 24 hours. The incidence of fever among the 37 individuals exposed to Omicron who were undergoing anti-tumor treatment with Marecipe was 0%, in contrast to 98% among their close contacts. Among 78 individuals at high-risk of progressing to severe COVID-19, the hospitalization rate was 0% for those treated with Marecipe AV, while it was 68% for untreated patients. The Marecipe AV herbal therapy has been shown to provide significant benefits in improving clinical symptoms, particularly by shortening the duration of fever associated with influenza.

Conclusion: Marecipe AV herbal therapy has demonstrated a clear and potent therapeutic effect against COVID-19 and influenza. The use of Marecipe therapeutics has the potential to terminate the clinical course of mild to moderate COVID-19 in all patients treated within a 48-hour window, while also effectively preventing the development of severe cases in all high-risk patients

Downloads

Published

2025-02-28

Issue

Vol. 95 No. 2 (2025): Volume 95, Issue 2

Section

Original Articles

How to Cite

Jiangnan Feng, Xianfu Li, Xue Feng, Shuzhen Wang, Xia Liu, Minghai Ma, Dengbin Zhu, et al. , trans. 2025. “An Herbal Remedy Exhibiting Potent Therapeutic Effects Against Respiratory Infectious Diseases in Humans, Including Covid-19 and Influenza”. Human Biology 95 (2): 1043-49. https://www.humbiol.org/Home/article/view/245.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >>